Samsung is reportedly planning to invest up to $100 million in Exo, a California-based startup pioneering AI-powered, handheld ultrasound devices. Backed by prominent venture firms like Sands Capital and Qubit Health Capital, the funding round aims to boost Exo’s development of accessible, mobile diagnostic tools, particularly suited for point-of-care use and resource-limited settings. Exo’s flagship product, Exo Iris, combines multiple ultrasound functions into a single portable device, while its SweepAI platform provides real-time, offline diagnostic insights using FDA-cleared artificial intelligence. Alongside Exo Works, a platform for managing patient data and clinical workflows, the startup offers a comprehensive solution for modern, data-driven healthcare. The investment may also lead to a strategic collaboration with Samsung Medison, potentially leveraging Samsung’s global reach and manufacturing power. This move signals Samsung’s growing commitment to digital health and Exo’s potential to transform global diagnostics with user-friendly, AI-enabled imaging tools. Read full article : https://www.techi.com/samsung-to-invest-100m-in-ai-ultrasound-startup-exo/